Cointime

TerrAscend

investment firm

About

TerrAscend is a Canadian cannabis company engaged in providing products, brands, and services to the cannabinoid market.

Highlights

Stock Symbol
cnsx:TER
Total Funding Amount
$349.15M $69M
Funding Rounds
10
Investors
4
Investments
5
Exits
1

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$55M
Industries
Cannabis,Clinical Trials,Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 2017
Operating Status
Active
Stock Symbol
cnsx:TER
Legal Name
TerrAscend Corporation

TerrAscend is a vertically-integrated Canadian cannabis company that strives to create and deliver quality products and services that meet the evolving needs of the cannabis market. It provides support to patients through its wholly-owned subsidiaries, Solace Health Inc., a licensed producer of cannabis under the Access to Cannabis for Medical Purposes Regulations, and Terra Health Network Inc., a provider of clinical support and education programs led by health care professionals.

TerrAscend offers prescription cannabinoids and medical cannabis solutions for patients suffering from chronic pain and debilitating illnesses and focuses on drug research and development, cannabis devices, delivery systems, and hemp health products.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
10
$349.15M $69M
TerrAscend has raised a total of $349.15M $69M in funding over 2 rounds. Their latest funding was raised on Nov 30, 2022 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 30, 2022 Post-IPO Debt $55M — — — Detail
Oct 12, 2022 Post-IPO Debt $45.50M 1 Pelorus Equity Group — Detail
Dec 18, 2020 Post-IPO Debt $120M — — — Detail
May 25, 2020 Post-IPO Equity $30M — — — Detail
Jan 13, 2020 Post-IPO Equity $33.50M — — — Detail
Show More

Investments

Number of Investments
Number of Lead Investments
5
0
TerrAscend has made 5 investments. Their most recent investment was on Apr 6, 2022, when Binance.US raised $200M.
Date Company Name
Round Money Raised Industry Lead Investor
Apr 6, 2022 Binance.US
Seed $200M Cryptocurrency —
Mar 11, 2020 Canopy Growth
Post-IPO Debt $58.80M Cannabis —
Sep 24, 2019 Stacks
Initial Coin Offering $23M Apps —
May 24, 2016 BitOasis
Seed — Bitcoin —
Feb 2, 2016 FiscalNote
Series C $10M Artificial Intelligence —

Investors

Number of Lead Investors
Number of Investors
3
4
TerrAscend is funded by 4 investors. Pelorus Equity Group and RIV Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Pelorus Equity Group Yes Post-IPO Debt
RIV Capital Yes Post-IPO Equity
JW Asset Management Yes Post-IPO Equity
Canopy Growth — Post-IPO Equity

Employee Profiles

Number of Employee Profiles
5
TerrAscend has 5 current employee profiles, including Board member Jason Wild
Jason Wild
Board member
Ziad Ghanem
Executive
Jodie Lampert
Executive
Lynn K. Gefen
Executive

Exits

TerrAscend has had 1 exits. TerrAscend most notable exits include Canopy Growth

Date Company Name Exit Type Industry
Jul 27, 2016 Canopy Growth IPO Cannabis Detail

Acquisition

TerrAscend has acquired 7 organizations. Their most recent acquisition was The Apothecarium on Feb 12, 2019. They acquired The Apothecarium for $118.40M.

Date Company Name
Industry Acquisition Type Price
Feb 12, 2019 The Apothecarium
Cannabis acquisition $ 118.40M Detail
Aug 2, 2019 Ilera Healthcare
Alternative Medicine acquisition — Detail
May 3, 2021 Keystone Canna Remedies
Cannabis acquisition $ 70M Detail
May 4, 2021 HMS Health
Cannabis acquisition $ 27.50M Detail
Sep 1, 2021 Gage Cannabis
Cannabis acquisition $ 545M Detail
Show More
Cointime
เนื้อหา
บริษัท